SPARK Europe Webinar Series | Dr. Réne Bernard: “EQIPD - a Quality Management System with Industrial Standards for Preclinical Research"

Abstract

Quality Management Systems have transformed industries over the past decades – with one exception: preclinical research.

EQIPD QS was developed by several industrial, academic and CRO partners within an IMI-funded project to ensure preclinical data quality, validity and traceability. It can be applied to all research in industry setting and ideally, to academic labs seeking collaboration with industry partners. The registered association GoEQIPD e.V. acts as guarantor of the quality system ensuring its actuality, its independence and overall awareness of research quality.

In this SPARK Europe Webinar Series, Dr. Réne Bernard, coordinator for Value and Open Science at the NeuroCure Excellence Cluster Berlin, will explain the hallmarks and latest developments of the EQIPD QS. Réne has worked as a scientist with preclinical research for several years in academic and industrial settings, co-developed the EQIPD QS and acts now as GoEQIPD board member. After this talk, you will know about:

• Why can it be useful to consider quality management in preclinical research?
• What are the advantages and benefits of EQIPD QS and EQIPD certification?
• What is the EQIPD framework?

SPARK Europe Webinar Series

The webinar series is organized by the different SPARK sites all over Europe including Israel: SPARK-BIH, SPARK Finland, SPARK at Masaryk University, SPARK FLI, SPARK Norway, SPARK Poland and SPARK Tel Aviv.

The series covers topics from design thinking to challenges in selling complex high-tech products from top-quality speakers around Europe and the US.

The online lectures take place once per month on Wednesday at 4-5 pm CET, and are open for all students and employees of SPARK associated organizations.

About SPARK-BIH and SPARK Europe

SPARK is an initiative created at Stanford University, to overcome challenges associated with translation of academic discoveries.

SPARK-BIH is located in Berlin and supports academic inventors with tailored education, mentorship and funding. The purpose of the program is to de-risk projects with high potential impact and accelerate the translation of academic inventions into outstanding medical products including drugs, diagnostics and medical devices.

SPARK Europe is the joint network of SPARK sites all over Europe plus Israel: SPARK-BIH, SPARK Finland, SPARK FLI, SPARK Masaryk University, SPARK Norway, SPARK Poland and SPARK Tel Aviv. It aims to fulfill SPARK’s mission of improving human health by uniting academics and industry experts around the globe to generate an efficient, effective and exciting pathway for the translation of academic discoveries and innovative solutions through education and project support.